Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-010116
Filing Date
2025-01-28
Accepted
2025-01-28 20:38:11
Documents
1
Period of Report
2025-01-28

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3180
  Complete submission text file 0000950170-25-010116.txt   4728
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Issuer) CIK: 0001422143 (see all company filings)

EIN.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FATE THERAPEUTICS, INC. 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address
Powl Brian T. (Reporting) CIK: 0001934232 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37620 | Film No.: 25566340